IPP Bureau
Ministry of Ayush signed MoU with Research and Information System for Developing Countries
By IPP Bureau - February 28, 2024
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
ABHA based Scan and Share Service facilitates 2 Crore instant OPD registrations nationwide
By IPP Bureau - February 28, 2024
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
Twinkle Khanna urges Indian women to check their iron levels
By IPP Bureau - February 27, 2024
‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms
Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India
By IPP Bureau - February 27, 2024
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Shilpa Medicare gets Europe approval for Varenicline Tablets, 0.5mg and 1mg
By IPP Bureau - February 27, 2024
Varenicline is indicated for smoking cessation in adults
Kilitch Drug India's subsidiary wins tender in Ethiopia
By IPP Bureau - February 27, 2024
The contract awarded to Kilitch Estro Biotech PLC entails the supply of pharmaceuticals with an order size amounting to US$ 9.13 million
Ministry of Ayush and Ministry of Women and Child Development join hands for Nutritional Improvement in adolescent girls through Ayurveda interventions
By IPP Bureau - February 27, 2024
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
VeerHealth Care announces expansion to enhance healthcare solutions
By IPP Bureau - February 26, 2024
VeerHealth Care will be raising Rs. 8 crores through bank borrowings
Concord Biotech receives GMP certificate from Kenya regulator
By IPP Bureau - February 26, 2024
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
Max Healthcare to acquire land parcel in Lucknow for new hospital
By IPP Bureau - February 26, 2024
The board gave in-principle approval for expansion of company's footprint in Lucknow
Piramal Pharma gets Form 483 with 2 observations from USFDA for Lexington, USA facility
By IPP Bureau - February 26, 2024
The observations do not pose any risk to site's compliance standards or its business continuity
Zydus receives WHO prequalification for Miltefosine formulation and API
By IPP Bureau - February 26, 2024
Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies
Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India
By IPP Bureau - February 24, 2024
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
_Rupak_Singla.jpg "India implementing largest digital programme for TB surveillance")
India implementing largest digital programme for TB surveillance
By IPP Bureau - February 24, 2024
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi
Orchid Pharma's 'Exblifep' receives USFDA approval
By IPP Bureau - February 24, 2024
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
